Latest News

• 
  Allergy

  New data reinforces efficacy of Tezspire in a broad population of severe asthma patients – Amgen

  Written by Charlie King | 22 Apr 2022

  Amgen announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed Tezspire (tezepelumab-ekko) demonstrated reductions in the annualized asthma… read more.

• 
  'In Discussion With'

  Clinical pharmacy services in the dermatology biologics clinic

  Written by Christine Clark | 22 Apr 2022

  Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool University Hospitals, was a recently-qualified independent prescriber when she managed the switch to biosimilar infliximab for the cohort of… read more.

• 
  Male & Female Health

  Alarmingly high rates of inappropriate antibiotic prescribing to older and Black patients, finds US study

  Written by Charlie King | 22 Apr 2022

  Almost three-quarters of antibiotics prescriptions to patients aged 65 years or older, and two thirds to Black patients, are inappropriate, according to a study analysing over 7 billion… read more.

• 
  Radiology

  Video radiology reports valuable for improving patient-centered care

  Written by Charlie King | 21 Apr 2022

  According to ARRS’ American Journal of Roentgenology (AJR), video radiology reports have the potential to improve radiologists’ communication with patients, highlighting the importance of imaging in patient-centered care. “Patient-centered video… read more.

• 
  Neurology

  How do our eyes stay focused on what we reach for? Researchers uncover how our gaze is “anchored” in the brain

  Written by Charlie King | 21 Apr 2022

  Keeping our eyes focused on what we reach for, whether it be an item at the grocery store or a ground ball on the baseball field, may appear… read more.

• 
  'In Discussion With'

  Working with patients with skin conditions

  Written by Christine Clark | 21 Apr 2022

  Feedback from a satisfied patient illustrates the impact that good pharmaceutical care can have on dermatological disease, according to Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool… read more.

• 
  Obstetrics & Gynaecology

  Novel combination treatment effective in recurrent ER-positive endometrial cancer

  Written by Bruce Sylvester | 20 Apr 2022

  Researchers from a phase 2 study report that combination treatment with abemaciclib and letrozole shrinks or stabilizes tumors in a majority of subjects diagnosed with recurrent or persistent… read more.

• 
  'In Discussion With'

  IV non-opioid analgesics – their role in multimodal analgesia and ERAS

  Written by Christine Clark | 20 Apr 2022

  Enhanced recovery after surgery (ERAS) offers many advantages including early functional recovery and reduced exposure to opioids.  In this series of short videos Dr Alexander Tzabazis, Deputy Director… read more.

• 
  Mental Health

  Psychiatric symptoms in Alzheimers disease

  Written by Charlie King | 20 Apr 2022

  In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occur… read more.

• 
  'In Discussion With'

  What a specialist dermatology pharmacist can offer

  Written by Christine Clark | 20 Apr 2022

  Kläre Bryant is an advanced clinical pharmacist who has been holding clinics for dermatology patients receiving biologics and other systemic treatments for more than nine years. IMI spoke… read more.

• 
  Cardiology

  About 1 in 4 adults has an often-missed liver disorder linked to higher heart disease risk

  Written by Charlie King | 19 Apr 2022

  It is estimated that about one in four adults worldwide has a liver condition that is a risk factor for heart disease, according to a new American Heart… read more.

• 
  Allergy

  New COVID-19 nasal spray outperforms current antibody treatments in mice

  Written by Charlie King | 19 Apr 2022

  A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human… read more.